Discount Generic Prescription Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00971022
Recruitment Status : Completed
First Posted : September 3, 2009
Last Update Posted : April 18, 2012
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

Brief Summary:

The goal of this study is to learn about the factors that influence people to take part in discount generic prescription programs.

The primary objective of this study is to identify the factors associated with awareness and utilization of discount generic prescription programs and how two low-income populations in Houston utilize the $4 for a 30-day supply or $10 for a 90-day supply, Generic Prescriptions Program offered by Kroger, Randalls, Target, Walmart, HEB, CVS, and Walgreens.

Condition or disease Intervention/treatment
Poverty Low-Income Population Behavioral: Survey Behavioral: Focus Group

Detailed Description:

If you agree to take part in this study, you will take part in a focus group. The focus group will consist of about 8 people who will discuss beliefs about generic medication, awareness of discount generic prescription programs, and use of the discount generic prescription program. The focus group will last about 90 minutes.

During the focus group, you will complete a form that asks for basic demographic information (such as your age and sex).

The focus group discussions will be taped, and the recorded tapes will be transcribed word-for-word. The taped recording of the focus group study will be stored in a safe and secured locker by the study chair. The taped recordings will be destroyed after 5 years.

Length of Study:

Your participation on this study will end once you complete the focus group.

This is an investigational study.

Study Type : Observational
Actual Enrollment : 574 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Discount Generic Prescription Utilization in Low-income Populations
Study Start Date : August 2009
Actual Primary Completion Date : May 2011
Actual Study Completion Date : May 2011

Group/Cohort Intervention/treatment
Low-income Populations Behavioral: Survey
20 minute survey to determine the relationship between awareness of the discount generic prescription program and utilization of the program.
Other Name: Questionnaire

Behavioral: Focus Group
5 - 8 focus groups of 6 - 10 people, lasting approximately 90 minutes

Primary Outcome Measures :
  1. Number of low-income adults who are aware of discount generic prescription programs (Survey) [ Time Frame: 12 Months (estimated survey completion time 20 minutes) ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Adults or an adult's family member, over the age of 18, with a low-income (less than $30,000/year) and a chronic health condition requiring prescriptions.

Inclusion Criteria:

  • Age 18 and older
  • Low-income (less than $30,000/year)
  • Ability to speak English
  • Ability to read and write in English
  • Chronic health condition requiring prescription medication or family member with chronic health condition requiring prescription medication.

Exclusion Criteria:

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00971022

United States, Texas
Independence Heights Community Health Center
Houston, Texas, United States, 77018
HOPE Clinic
Houston, Texas, United States, 77036
Second Mile Mission Center
Houston, Texas, United States, 77477
Sponsors and Collaborators
M.D. Anderson Cancer Center
Study Chair: Lovell A. Jones, PHD, BS, MA UT MD Anderson Cancer Center
Principal Investigator: Anthony Omojasola, DRPH UT MD Anderson Cancer Center

Additional Information:
Responsible Party: M.D. Anderson Cancer Center Identifier: NCT00971022     History of Changes
Other Study ID Numbers: 2009-0340
First Posted: September 3, 2009    Key Record Dates
Last Update Posted: April 18, 2012
Last Verified: April 2012

Keywords provided by M.D. Anderson Cancer Center:
Low-income populations
Chronic health condition
Prescription medication
Prescription drugs
Discount generic prescription programs
Focus Group